<i>Fusobacterium nucleatum</i> as a two-hit amplifier in colorectal cancer pathogenesis: intersection of local and systemic mechanisms via the gut-kidney axis.

collaborates with genetic lesions to accelerate disease progression. This framework provides a crucial foundation for developing innovative diagnostics and microbe-targeted therapies-such as phage therapy and vaccines-to substantially improve the prognosis of patients with CRC.